Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FCM vs Oral Iron in Anemia from Heavy Uterine Bleeding
NCT00395993Phase 3Completed
- Sponsor
- American Regent, Inc.
- Start
- May 2005
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by American Regent, Inc.. Started May 2005; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT00395993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00395993.